KLF12 and neoplasm: To determine whether the anti-tumor effects of miR-382 on these OS cells could be partly explained by its targeting of KLF12 and HIPK3, we first analyzed how KLF12 and HIPK3 overexpression affected in vitro and in vivo cell growth and chemosensitivity.